How BioArctic Is Transforming Alzheimer’s Research

Oskar Bosson, VP and Head of Investor Relations and Communications at BioArctic, shares the company’s mission to combat neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. Oskar discusses BioArctic’s groundbreaking brain transporter technology, the impact of their Nasdaq Stockholm listing, and how their research helped revive a field once known as the “Graveyard of Science.”